Rafael Fonseca, MD | oneAMYLOIDOSISvoice

Rafael Fonseca, MD

Division of Hematology/Oncology
Mayo Clinic
13400 E. Shea Blvd
Scottsdale, Arizona, United States

Rafael Fonseca is a clinical investigator for the Damon Runyon Cancer Research Fund. Dr. Fonseca earned his medical degree at Universidad Anahuac, Mexico. He completed a Residency in Internal Medicine at the University of Miami, Florida, and a Fellowship in Hematology and Oncology at Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota. Dr. Fonseca’s research interests are in conditions such as multiple myeloma and related disorders, cytogenetics and amyloidosis.

Dr. Fonseca’s practice focuses on diagnosing and treating plasma cell disorders. He also leads multiple myeloma research team in its effort to develop a better understanding of the disease and its impact on patients. In his laboratory, Dr. Fonseca has led his team of researchers in concentrating on the genetic nature of clonal cells of plasma cell disorders. He also has experience in myeloma bone disease, prognostic markers and development of new therapies for the disease.


Representative Publications:

Incidence of skeletal-related events among multiple myeloma patients in the United States at oncology clinics: Observations from real-world data

High-Dose Chemotherapy with Early Autologous Stem Cell Transplantation Compared to Standard Dose Chemotherapy or Delayed Transplantation in Patients with Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-Analysis

Value and Cost of Myeloma Therapy-We Can Afford It 

Phase 1/2 trial of ixazomib, cyclophosphamide and dexamethasone in patients with previously untreated symptomatic multiple myeloma 

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.